Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
Chronic infections with either hepatitis B or C virus (HBV or HCV) are among the most common risk factors for developing hepatocellular carcinoma (HCC). The hepatocarcinogenic potential of these viruses is mediated through a wide range of mechanisms, including the induction of chronic inflammation a...
Guardado en:
Autores principales: | Saleh A. Alqahtani, Massimo Colombo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8429602c2ddf40bd9c18d7d316a6e1ac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
por: Toofan Datfar, et al.
Publicado: (2021) -
Serum soluble Toll-like receptor 4 and the risk of hepatocellular
carcinoma in hepatitis C virus patients
por: Maha Elkammah, et al.
Publicado: (2021) -
DEMOGRAPHICS AND CORRELATION OF RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS PRESENTING TO A TERTIARY CARE FACILITY IN PAKISTAN
por: Hafsa Rashid, et al.
Publicado: (2021) -
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Eun Jin Sun, et al.
Publicado: (2021) -
The Role of Exosomes in Viral Hepatitis and Its Associated Liver Diseases
por: Hao Zhou, et al.
Publicado: (2021)